VHL Tumor Suppressor As a Novel Potential Candidate Biomarker in Papillary Thyroid Carcinoma.
Bosnian Journal of Basic Medical Sciences(2022)
摘要
Papillary thyroid carcinoma (PTC) is the most common type of endocrine cancer, with an increasing incidence worldwide. The treatment of PTC is currently the subject of clinical controversy, making it critically important to identify molecular markers that would help improve the risk stratification of PTC patients and optimize the therapeutic approach. The VHL tumor suppressor gene has been implicated in tumorigenesis of various types of carcinoma and linked with their aggressive biological behavior. The role of VHL in the origin and development of PTC has only recently begun to be revealed. In this narrative review we attempt to summarize the existing knowledge that implicates VHL in PTC pathogenesis and to outline its potential significance as a candidate molecular biomarker for the grouping of PTC patients into high and low risk groups.
更多查看译文
关键词
Papillary thyroid cancer,papillary thyroid carcinoma (PTC),Von Hippel-Lindau (VHL),biomarker,risk stratification,tumor suppressor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要